High
3.196
Open
3.150
VWAP
3.10
Vol
237.99K
Mkt Cap
110.46M
Low
3.060
Amount
736.67K
EV/EBITDA(TTM)
--
Total Shares
28.81M
EV
91.45M
EV/OCF(TTM)
--
P/S(TTM)
3.16
Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper-limb paralysis. It develops and markets the MyoPro product line. MyoPro is a powered upper-limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of certain patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury, ALS or other neuromuscular disease or injury. MyoPro senses a patient’s own electromyography (EMG) signals through non-invasive sensors on the arm, and can restore an individual’s ability to perform activities of daily living, including feeding themselves, carrying objects and doing household tasks. It provides devices directly to patients and bill their insurance companies directly. It also sells its products through various other sales channels, including through orthotics and prosthetics providers, the veteran’s administration, and others.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2025Q3
FY2025Q2
18.01M
+49.24%
--
--
13.43M
+45.8%
--
--
9.17M
+21.89%
--
--
Estimates Revision
The market is revising Upward the revenue expectations for Myomo, Inc. (MYO) for FY2025, with the revenue forecasts being adjusted by 15.74% over the past three months. During the same period, the stock price has changed by -36.04%.
Revenue Estimates for FY2025
Revise Upward

+15.74%
In Past 3 Month
Stock Price
Go Down

-36.04%
In Past 3 Month
6 Analyst Rating

197.39% Upside
Wall Street analysts forecast MYO stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MYO is 9.13 USD with a low forecast of 6.75 USD and a high forecast of 11.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
6 Buy
0 Hold
0 Sell
Strong Buy

197.39% Upside
Current: 3.070

Low
6.75
Averages
9.13
High
11.00

197.39% Upside
Current: 3.070

Low
6.75
Averages
9.13
High
11.00
Craig-Hallum
Craig Knickerbocker
Strong Buy
Maintains
$11 → $10
2025-05-08
Reason
Craig-Hallum
Craig Knickerbocker
Price Target
$11 → $10
2025-05-08
Maintains
Strong Buy
Reason
Ascendiant Capital
Edward Woo
Strong Buy
Maintains
$9 → $11
2025-03-17
Reason
Ascendiant Capital
Edward Woo
Price Target
$9 → $11
2025-03-17
Maintains
Strong Buy
Reason
HC Wainwright & Co.
Sean Lee
Strong Buy
Maintains
$7.5 → $9.5
2025-03-12
Reason
HC Wainwright & Co.
Sean Lee
Price Target
$7.5 → $9.5
2025-03-12
Maintains
Strong Buy
Reason
Craig-Hallum
Craig Knickerbocker
Strong Buy
Maintains
$9 → $11
2025-03-11
Reason
Craig-Hallum
Craig Knickerbocker
Price Target
$9 → $11
2025-03-11
Maintains
Strong Buy
Reason
Craig-Hallum
Craig Knickerbocker
Strong Buy
Maintains
$7 → $9
2024-12-13
Reason
Craig-Hallum
Craig Knickerbocker
Price Target
$7 → $9
2024-12-13
Maintains
Strong Buy
Reason
Myomo announced that it intends to offer and sell shares of its common stock in an underwritten public offering. Myomo expects to use the net proceeds of the offering, together with its existing cash and cash equivalents, to accelerate its revenue growth by funding an increase in advertising expenses and headcount to support the expected revenue growth in Myomo's direct billing channel, along with investments in systems to support growth in the O&P channel and in scaling its operations. In addition, the net proceeds of the offering will be used to fund product development and sustaining engineering activities to enhance the current MyoPro product line and to develop the next generation of Myomo's products, with the remainder for working capital and general corporate purposes. Craig-Hallum Capital Group is acting as the sole managing underwriter for the offering.
HC Wainwright & Co.
Sean Lee
Strong Buy
Reiterates
$7.5
2024-11-13
Reason
HC Wainwright & Co.
Sean Lee
Price Target
$7.5
2024-11-13
Reiterates
Strong Buy
Reason
See All Ratings
Valuation Metrics
The current forward P/E ratio for Myomo Inc (MYO.A) is -24.20, compared to its 5-year average forward P/E of -11.30. For a more detailed relative valuation and DCF analysis to assess Myomo Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A
5Y Average PE
-11.30
Current PE
-24.20
Overvalued PE
2.49
Undervalued PE
-25.10
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A
5Y Average EV/EBITDA
-11.98
Current EV/EBITDA
-23.24
Overvalued EV/EBITDA
11.22
Undervalued EV/EBITDA
-35.17
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Fair
5Y Average PS
2.63
Current PS
2.19
Overvalued PS
4.23
Undervalued PS
1.03
Financials
Annual
Quarterly
FY2025Q1
YoY :
+161.88%
9.83M
Total Revenue
FY2025Q1
YoY :
-9.48%
-3.52M
Operating Profit
FY2025Q1
YoY :
-9.66%
-3.47M
Net Income after Tax
FY2025Q1
YoY :
-20.00%
-0.08
EPS - Diluted
FY2025Q1
YoY :
+1.28%
-3.35M
Free Cash Flow
FY2025Q1
YoY :
+9.78%
67.23
Gross Profit Margin - %
FY2025Q1
YoY :
-65.51%
-35.24
Net Margin - %
Trading Trends
Insider
Insiders areBuying! The selling amount has increased 954.34% over the last month.
Sold
0-3
Months
412.6K
USD
2
3-6
Months
0.0
USD
0
6-9
Months
33.3K
USD
2
0-12
Months
0.0
USD
0
Bought
0-3
5
427.1K
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
1
900.0K
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders areBuying! The selling amount has increased 954.34% over the last month.
Sold
0-3
Months
412.6K
USD
2
3-6
Months
0.0
USD
0
6-9
Months
33.3K
USD
2
0-12
Months
0.0
USD
0
Bought
0-3
5
427.1K
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
MYO News & Events
Events Timeline
2025-05-07 (ET)
2025-05-07
17:12:40
Myomo reports Q1 EPS (8c), consensus (8c)

2025-03-10 (ET)
2025-03-10
16:12:32
Myomo reports Q4 EPS (1c), consensus (2c)

2024-12-04 (ET)
2024-12-04
15:07:32
Myomo announces common stock offering, no amount given

Sign Up For More Events
Sign Up For More Events
News
1.0
05-01NewsfilterMyomo to Host Investor & Analyst Day Event on June 18, 2025
5.0
04-30NewsfilterMyomo Launches the MyoPro® 2x
5.0
04-10NewsfilterMyomo Announces Upcoming Changes to its Board of Directors
Sign Up For More News
People Also Watch

COF
Capital One Financial Corp
191.080
USD
-0.51%

QS
Quantumscape Corp
4.320
USD
+8.27%

TTD
Trade Desk Inc
76.940
USD
+1.16%

IDXX
IDEXX Laboratories Inc
514.330
USD
-0.42%

PTON
Peloton Interactive Inc
7.170
USD
-5.28%

MNDY
Monday.Com Ltd
297.195
USD
-0.64%

LCID
Lucid Group Inc
2.630
USD
-0.38%

FSK
FS KKR Capital Corp
21.330
USD
+0.05%

LYFT
Lyft Inc
15.980
USD
-2.08%

ENVX
Enovix Corp
8.300
USD
+3.36%
FAQ

What is Myomo Inc (MYO) stock price today?
The current price of MYO is 3.07 USD — it has decreased -2.23 % in the last trading day.

What is Myomo Inc (MYO)'s business?

What is the price predicton of MYO Stock?

What is Myomo Inc (MYO)'s revenue for the last quarter?

What is Myomo Inc (MYO)'s earnings per share (EPS) for the last quarter?

What changes have occurred in the market's expectations for Myomo Inc (MYO)'s fundamentals?

How many employees does Myomo Inc (MYO). have?
